Global Pharma Excipients Market Size By Type (Polymers, Alcohols), By Application (Oral Solid Dosage Forms (OSDF), Others), By Region, And Segment Forecasts, 2023 to 2032

The Global Pharma Excipients Market was valued at USD 10.7 billion in 2023 and is projected to reach USD 17.4 billion by 2031, expanding at a CAGR of 6.2% during the forecast period from 2023 to 2031. The increasing demand for innovative drug formulations, the surge in generic drug production, and advancements in drug delivery systems are key factors driving the market growth. Pharma excipients, which are non-active substances used to support the delivery of the active pharmaceutical ingredient (API), play a critical role in enhancing drug stability, bioavailability, and patient acceptability.

Drivers:

1. Rising Demand for Functional Excipients:

Pharmaceutical manufacturers are increasingly focusing on advanced functional excipients that can provide targeted delivery, controlled release, and improved solubility of active ingredients. This shift toward specialized formulations is fueling market expansion.

2. Surge in Generic Drug Production:

The expiration of several key drug patents and a growing emphasis on cost-effective healthcare solutions have led to a substantial increase in generic drug manufacturing, thereby boosting the need for quality excipients.

3. Growth in Biopharmaceuticals and Novel Drug Delivery Systems:

As biologics gain traction in therapeutic applications, excipients are becoming crucial in stabilizing proteins and peptides. Innovative drug delivery platforms such as nano-carriers and liposomes are also enhancing excipient demand.

Restraints:

1. Regulatory Challenges:

The pharma excipients market faces stringent regulatory scrutiny globally. Differing regional regulations and approval processes can delay product launches and limit market access for newer excipient types.

2. Complexity in Excipient Compatibility:

Excipients must be chemically and physically compatible with APIs. Incompatibility issues can complicate formulation development, increasing R&D timelines and costs.

Opportunity:

1. Expanding Pharmaceutical Manufacturing in Emerging Markets:

Emerging economies in Asia-Pacific, Latin America, and Africa are investing heavily in pharmaceutical infrastructure, creating lucrative opportunities for excipient suppliers.

2. Advancement in Oral Solid Dosage Formulations:

Continued innovation in oral drug delivery, such as orally disintegrating tablets (ODTs) and sustained-release formulations, is expected to propel excipient usage globally.

Market by System Type Insights:

By excipient type, the binders segment held the largest market share in 2023, owing to their widespread application in tablet and capsule formulations. Binders help hold ingredients together and influence the release profile of drugs. Meanwhile, coating agents are anticipated to exhibit the fastest growth due to rising demand for controlled-release and taste-masking technologies.

Market by End-use Insights:

The pharmaceutical manufacturers segment emerged as the largest end-user in 2023, driven by their dominant role in formulation development and large-scale production. The contract manufacturing organizations (CMOs) segment is also growing rapidly as companies increasingly outsource drug formulation and production to reduce operational costs and focus on core R&D activities.

Market by Regional Insights:

North America dominated the global pharma excipients market in 2023, accounting for the highest share due to a strong pharmaceutical manufacturing base, favorable reimbursement policies, and a high volume of drug approvals. However, Asia-Pacific is expected to record the highest CAGR over the forecast period, supported by rising healthcare expenditure, increasing local drug production, and growing investments from multinational pharma companies.

Competitive Scenario:

Key players in the global pharma excipients market include BASF SE, Ashland Global Holdings Inc., DuPont, Roquette Frères, Croda International Plc, Evonik Industries AG, DFE Pharma, Lubrizol Corporation, Kerry Group plc, and Colorcon Inc. These companies are focused on product innovation, mergers & acquisitions, and strategic collaborations to enhance their product offerings and geographical reach.

Scope of Work – Global Pharma Excipients Market

Report Metric Details

Market Size (2023) USD 10.7 billion

Projected Market Size (2031) USD 17.4 billion

CAGR (2023–2031) 6.2%

Market Segments By Excipient Type (Binders, Fillers, Coatings, etc.), By End-use, By Region

Growth Drivers Demand for functional excipients, rise in generic drug production

Opportunities Emerging pharma markets, innovations in drug delivery systems

Key Market Developments:

April 2023: BASF SE launched a new line of multifunctional excipients aimed at enhancing drug solubility and stability in complex formulations.

August 2023: DuPont announced an expansion of its excipient production facility in India to cater to growing demand from emerging markets.

February 2024: Roquette Frères introduced plant-based excipients tailored for pediatric and geriatric drug formulations, focusing on improved palatability and safety.

January 2025: Colorcon Inc. partnered with a major pharmaceutical company to develop next-generation film coatings for modified-release oral solid dosage forms.

FAQs:

1. What is the current market size of the Global Pharma Excipients Market?

The market was valued at USD 10.7 billion in 2023.

2. What is the major growth driver of the Global Pharma Excipients Market?

The rising demand for functional excipients and increased production of generic drugs are key growth drivers.

3. Which is the largest region during the forecast period in the Global Pharma Excipients Market?

North America is currently the largest regional market, while Asia-Pacific is expected to grow at the fastest pace.

4. Which segment accounted for the largest market share in the Global Pharma Excipients Market?

The binders segment led the market by excipient type in 2023.

5. Who are the key market players in the Global Pharma Excipients Market?

Key players include BASF SE, DuPont, Roquette Frères, Ashland Global, and Evonik Industries, among others.